|
HY-100620-10mg
|
MedChemexpress LLC
|
RPR121056 [CAS 181467-56-1]
|
|
Cancer-programmed cell death
|
|
|
HY-100620-100mg
|
MedChemexpress LLC
|
RPR121056 [CAS 181467-56-1]
|
|
Cancer-programmed cell death
|
|
|
HY-100620-25mg
|
MedChemexpress LLC
|
RPR121056 [CAS 181467-56-1]
|
|
Cancer-programmed cell death
|
|
|
HY-100620-5mg
|
MedChemexpress LLC
|
RPR121056 [CAS 181467-56-1]
|
|
Cancer-programmed cell death
|
|
|
HY-100620-50mg
|
MedChemexpress LLC
|
RPR121056 [CAS 181467-56-1]
|
|
Cancer-programmed cell death
|
|
|
HY-103255-10mg
|
MedChemexpress LLC
|
CFM-4 [CAS 331458-02-7]
|
|
Cancer-programmed cell death
|
|
|
HY-103255-25mg
|
MedChemexpress LLC
|
CFM-4 [CAS 331458-02-7]
|
|
Cancer-programmed cell death
|
|
|
HY-103255-5mg
|
MedChemexpress LLC
|
CFM-4 [CAS 331458-02-7]
|
|
Cancer-programmed cell death
|
|
|
HY-105999-5mg
|
MedChemexpress LLC
|
APC 366 [CAS 158921-85-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-105999B-1mg
|
MedChemexpress LLC
|
APC 366 (TFA) [CAS 2421110-28-1]
|
|
|
|
|
HY-108442-10mg
|
MedChemexpress LLC
|
JW67 [CAS 442644-28-2]
|
|
Cancer-programmed cell death
|
|
|
HY-108442-100mg
|
MedChemexpress LLC
|
JW67 [CAS 442644-28-2]
|
|
Cancer-programmed cell death
|
|
|
HY-108442-25mg
|
MedChemexpress LLC
|
JW67 [CAS 442644-28-2]
|
|
Cancer-programmed cell death
|
|
|
HY-108442-5mg
|
MedChemexpress LLC
|
JW67 [CAS 442644-28-2]
|
|
Cancer-programmed cell death
|
|
|
HY-108442-50mg
|
MedChemexpress LLC
|
JW67 [CAS 442644-28-2]
|
|
Cancer-programmed cell death
|
|
|
HY-110287-1mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
|
HY-110287-10mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
|
HY-110287-100mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
|
HY-110287-25mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
|
HY-110287-5mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
|
HY-110287-50mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-10mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-100mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-25mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-5mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
